Evolent Health Overview
Industry: Health Information Services
Sector: Healthcare
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology, cardiology, and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia. Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment Read MoreMavefund brings filings, fundamentals, valuation, price history and news for Evolent Health into one research view. The sections below show what strengthens or weakens the research case.
Score
Reported Results
What the company reported, with filing details kept small.
Quarterly result summary
Revenue was $2.4B (reported). Adjusted EBITDA was $22.1M (-40% YoY). Cash was $142M.
Revenue
$2.4B
reported
Adjusted EBITDA
$22.1M
-40% YoY
Cash
$142M
reported
What changed
- Revenue reported to $2.4B.
- Adjusted EBITDA -40% YoY to $22.1M.
Guidance / outlook
The Company expects to deploy approximately $25 million to $30 million in cash for capitalized software development during 2026. This “Business Outlook” section contains forward-looking statements, and actual results may differ materially.
Earnings release
Open filing
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
SEC filing
8-K
May 07, 2026
SEC filing
10-Q
May 07, 2026
SEC filing
10-K
Feb 25, 2026
Earnings release
Earnings release
Feb 24, 2026
SEC filing
8-K
Feb 24, 2026
SEC filing
10-Q
Nov 07, 2025
SEC filing
8-K
Nov 06, 2025
Earnings release
Earnings release
Nov 06, 2025
SEC filing
10-Q
Aug 11, 2025
SEC filing
8-K
Aug 07, 2025
Earnings release
Earnings release
Aug 07, 2025
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
Why Evolent Health (EVH) Stock Is Nosediving
Headline from Yahoo Finance: Why Evolent Health (EVH) Stock Is Nosediving.
Evolent Health: The De-Risking Is Working, But Leverage Keeps Me On Hold (NYSE:EVH)
Headline from Seeking Alpha: Evolent Health: The De-Risking Is Working, But Leverage Keeps Me On Hold (NYSE:EVH).
Earnings Per Share
Score 3.00/5
Evolent Health boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
In
Health Information Services industry
, National Research Corp
, HealthStream Inc
, VEEVA SYSTEMS INC
are companies with high ratings.
Return on Equity
Score 2.00/5
Evolent Health exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
Metric chart temporarily unavailable.
Net Margin
Score 2.24/5
Evolent Health
olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
Metric chart temporarily unavailable.
Leverage
Score 1.85/5
Evolent Health
registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
have achieved high scores.
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Verified SEC statements load when this section enters view.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.
Financial Ratio
Yearly
Quarterly
Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios